Recently, not only hormone receptors, such as estrogen receptor or progesterone receptor (ER/PR), but also biomarkers that regulate tumor cell proliferation, such as the Ki67 index or human epidermal growth factor receptor type 2 (HER2) status, have been introduced as predictive indicators for prognosis[4]. This evidence concerns the gene ERBB2 and neoplasm.